Ischemia-Reperfusion Injury

Ischemia-reperfusion injury is the tissue damage that arises when blood flow is restored to an organ after a period without adequate circulation. Counterintuitively, the restoration of oxygenated blood — not only the preceding ischemia — drives part of the injury, which is why it is a defining concern when a preserved donor organ is reperfused in the recipient.

Definition

Ischemia-reperfusion injury is the cellular, microvascular, and inflammatory damage that occurs when oxygenated blood flow is reintroduced to tissue that has undergone a period of ischemia, such that the reperfusion itself contributes to injury beyond that caused by the ischemic interval alone.

Scope

The topic explains why reperfusion adds to ischemic damage, the principal mechanisms involved, and how this process links preservation conditions to graft outcomes. It is framed as a reference description of the pathophysiology; it does not provide treatment protocols, drug regimens, or individualized prevention strategies.

Core questions

• Why does restoring blood flow cause additional injury rather than simply reversing ischemia?
• Which cellular and microvascular events are set in motion at reperfusion?
• How does this process connect organ preservation to the function of a transplanted graft?

Key concepts

• Reactive oxygen species burst at reperfusion
• Calcium overload and mitochondrial dysfunction
• Innate immune and complement activation
• Microvascular dysfunction and no-reflow
• Endothelial injury
• Sterile inflammation

Mechanisms

During ischemia, oxygen and substrate deprivation impair mitochondrial energy production and disturb cellular ion homeostasis, including intracellular calcium handling. On reperfusion, the sudden reintroduction of oxygen generates a burst of reactive oxygen species, while accumulated ischemic changes and cell death release signals that activate complement and innate immunity, producing a sterile inflammatory response (Collard & Gelman, 2001; Eltzschig & Collard, 2004). Endothelial injury and microvascular dysfunction can impede effective perfusion even after macroscopic flow is restored. These pathways are shared across organs and form the mechanistic bridge from preservation conditions to clinical graft outcomes (Eltzschig & Eckle, 2011).

Clinical relevance

Because reperfusion injury contributes to early graft dysfunction, it is central to understanding why preservation method and ischemic time affect transplant outcomes, and it is also relevant beyond transplantation in settings such as myocardial infarction reperfusion. This entry describes the mechanism for reference and does not recommend specific preventive or therapeutic interventions.

Evidence & guidelines

The pathophysiology of ischemia-reperfusion injury is documented in mechanistic and translational reviews that synthesize experimental and clinical observation (Collard & Gelman, 2001; Eltzschig & Collard, 2004; Eltzschig & Eckle, 2011). Clinical management of the downstream states is addressed in the delayed graft function and primary nonfunction entries.

History

The recognition that reperfusion itself can injure tissue, rather than merely revealing prior ischemic damage, reframed the understanding of organ recovery in the late twentieth century. Successive reviews consolidated the roles of reactive oxygen species, calcium overload, endothelial dysfunction, and innate-immune activation, and connected the mechanism to translational efforts to protect organs (Collard & Gelman, 2001; Eltzschig & Collard, 2004; Eltzschig & Eckle, 2011).

Key figures

• Holger Eltzschig
• Charles Collard
• Simon Gelman

Seminal works

• eltzschig-eckle-2011
• collard-gelman-2001
• eltzschig-2004

Frequently asked questions

How can restoring blood flow be harmful?

When oxygenated blood returns to ischemic tissue, it triggers a burst of reactive oxygen species and activates inflammatory and immune pathways, while microvascular dysfunction can block effective perfusion. These reperfusion events add to the damage already caused by the lack of blood flow.

Why does ischemia-reperfusion injury matter in transplantation?

A donor organ is necessarily ischemic during preservation and is then reperfused in the recipient. The severity of the resulting injury helps determine whether the graft functions promptly, functions slowly, or fails, linking preservation conditions to outcome.